People in the U.S. and in some other countries are headed toward a “NASH” crisis, a not very well-known but pervasive disease associated with many…
University of Minnesota Medical School researchers were awarded a $5 million grant from the National Institute of Health (NIH) to conduct a clinical trial that…
A team of investigators from the University of Texas Health Science Center at San Antonio (also referred to as UT Health San Antonio), University Health, and…
NASH is a growing problem in American society—impacting over 16 million people with projected growth by 2030 as high as 63%. The disease is associated with…
Obesity is a recognized risk factor for severe COVID-19, possibly related to chronic inflammation that disrupts immune and thrombogenic responses to pathogens as well as…
A Novartis investigational product called Bimagrumab recently raised attention in the obesity research community. The human monoclonal antibody was designed to treat muscle loss and weakness but unfortunately…
A January 13 study published in JAMA Network Open looks at the “Effect of Bimagrumab vs. Placebo on Body Fat Mass Among Adults With Type…
This week, Rhythm Pharmaceuticals, a biopharmaceutical company specializing in the treatment of rare genetic diseases surrounding obesity, announced the U.S. Food & Drug Administration’s (FDA)…
Obesity represents big business and big problems. The condition has essentially tripled since the 1970s as raising middle classes around the world, couple with associated…
Kaiser Permanente Southern California researchers reviewed data covering almost 7,000 COVID-19 patients treated between February and May 2020. Nearly half of these patients were considered…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
